z-logo
Premium
Heparin cofactor II in adults and infants with thrombosis and DIC
Author(s) -
Chuansumrit Ampaiwan,
MancoJohnson Marilyn J.,
Hathaway William E.
Publication year - 1989
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830310207
Subject(s) - heparin cofactor ii , medicine , coagulopathy , gestational age , gastroenterology , heparin , thrombosis , reference range , protein c , pediatrics , pregnancy , antithrombin , biology , genetics
Heparin cofactor II (HC II) was measured by a chromogenic activity assay in normal preterm infants (gestational age, 28–36 weeks; n = 17; 29% ± 11.5 [mean ± 1 SD], range 11–51), normal full‐term infants (n = 18; 49% ± 6.6 [mean ± 1 SD], range 36–58), and normal adults (n = 38; 101% ± 14 [mean ± 1 SD], range 73–130). Normal children attained adult levels at approximately 5 to 7 months of age. The lower values in preterm and term infants most likely reflect immature liver function. Neither adults and children with a history of thrombosis with prior negative evaluation (n = 74), patients with documented protein C and protein S deficiency (n = 4), nor sick infants without evidence of consumptive coagulopathy (n = 15) had significantly lower levels of HC II activity. Infants with disseminated intravascular coagulation (n = 2) had strikingly lower levels of HC II activity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom